Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Larson

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Role of the gamma-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin-heparinH C Whinna, E B Lesesky, D M Monroe, et al.
Biochemistry|May 16, 1998
Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesiclesP J Larson, R M Camire, D Wong, et al.
Cancer Nursing|August 6, 1998
The PRO-SELF Mouth Aware program: an effective approach for reducing chemotherapy-induced mucositisP J Larson, C Miaskowski, L MacPhail, et al.
The Journal of Biological Chemistry|February 16, 1996
Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIaP J Larson, S A Stanfield-Oakley, W J VanDusen, et al.
Journal of Clinical Pharmacology|April 16, 2005
Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteersJ A Wagner, P J Larson, S Weiss, et al.
Clinical Science (London, England : 1979)|April 21, 1999
Acute effect of ephedrine on 24-h energy balanceJ R Shannon, K Gottesdiener, J Jordan, et al.
Journal of Clinical Pharmacology|January 6, 2001
Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteersJ I Schwartz, M De Smet, P J Larson, et al.
Transfusion|July 1, 1997
The presurgical management with erythrocytapheresis of a patient with a high-oxygen-affinity, unstable Hb variant (Hb Bryn Mawr)P J Larson, D F Friedman, M P Reilly, et al.
Oncology Nursing Forum|July 1, 1996
Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapyM J Dodd, P J Larson, S L Dibble, et al.
Blood|April 16, 1998
Tissue factor regulates plasminogen binding and activationZ Fan, P J Larson, J Bognacki, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Role of the gamma-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin-heparinH C Whinna, E B Lesesky, D M Monroe, et al.
Biochemistry|May 16, 1998
Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesiclesP J Larson, R M Camire, D Wong, et al.
Cancer Nursing|August 6, 1998
The PRO-SELF Mouth Aware program: an effective approach for reducing chemotherapy-induced mucositisP J Larson, C Miaskowski, L MacPhail, et al.
The Journal of Biological Chemistry|February 16, 1996
Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIaP J Larson, S A Stanfield-Oakley, W J VanDusen, et al.
Journal of Clinical Pharmacology|April 16, 2005
Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteersJ A Wagner, P J Larson, S Weiss, et al.
Clinical Science (London, England : 1979)|April 21, 1999
Acute effect of ephedrine on 24-h energy balanceJ R Shannon, K Gottesdiener, J Jordan, et al.
Journal of Clinical Pharmacology|January 6, 2001
Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteersJ I Schwartz, M De Smet, P J Larson, et al.
Transfusion|July 1, 1997
The presurgical management with erythrocytapheresis of a patient with a high-oxygen-affinity, unstable Hb variant (Hb Bryn Mawr)P J Larson, D F Friedman, M P Reilly, et al.
Oncology Nursing Forum|July 1, 1996
Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapyM J Dodd, P J Larson, S L Dibble, et al.
Blood|April 16, 1998
Tissue factor regulates plasminogen binding and activationZ Fan, P J Larson, J Bognacki, et al.
Pageof 5